North America will continue to drive the global neurostimulation devices market through 2024, according to a Brand Essence Market Research report.
Here are five observations:
1. Abbott, Boston Scientific, LiveNova (Cyberonics), Nevro Corp., Autonomic Technologies, Inspire Medical System and NeuroPace are all key market players.
2. The growing geriatric population and rise in prevalence of neurological diseases will spark market growth. Opportunities for new technology development will also boost the market.
3. The costliness of neurological disease treatment and dearth of trained professionals will stunt market growth, however.
4. Europe is the second greatest contributor to the global market, with an anticipated increase in research and development in the field.
5. The Asia-Pacific region will witness market growth because of more government efforts highlighting public health.
More aritcles on devices:
K2M exceeds 100th-product milestone with OZARK Cervical Plate Systems clearance: 4 highlights
Medtronic whistleblower lawsuit to play out in court: 3 insights
Stryker, Medtronic, K2M & more: 11 device company notes